期刊文献+

热休克蛋白60在多西紫杉醇治疗激素非依赖性前列腺癌过程中的差异表达

Differential expressions of HSP60 in docetaxel treatment on advanced hormone-resistant prostate cancer
原文传递
导出
摘要 目的分别比较热休克蛋白60(HSP60)在多西紫杉醇(Docetaxel)诱导前列腺癌PC-3细胞凋亡及耐药前后表达的差异,并探讨其意义。方法采用20μmol/L Docetaxel诱导PC-3细胞凋亡,后采用逐渐加量的方式培养PC-3细胞Docetaxel耐药株;采用双向荧光差异凝胶电泳(DIGE)技术定量筛选未处理组PC-3细胞与凋亡PC-3细胞,及PC-3细胞敏感株与耐药株的差异蛋白,并采用基质辅助激光解吸电离飞行时间质谱(MALDI-TOF-MS)技术对其进行成分鉴定,进而检测HSP60的表达。结果 HSP60在Docetaxel诱导PC-3凋亡细胞中表达上调,在Docetaxel耐药株中表达下调。结论 HSP60在PC-3凋亡细胞中高表达,在Docetaxel耐药株中的低表达,提示其可能与PC-3细胞的凋亡及耐药有重要关系。 Objective To identify the different expressions of heat shock protein 60(HSP60) in apoptosis and drug resistance induced by docetaxel in androgen independent prostate cancer PC-3 cells,and investigate its significance.Methods Apoptotic PC-3 cells were induced by 20 μmol/L docetaxel.Docetaxel-resistant PC-3 cells were produced by breeding with increasing doses of docetaxel.Fluorescence two-dimensional difference gel electrophoresis(DIGE) was used to quantatively screen the differentially expressed proteins between untreated PC-3 cells and apoptotic PC-3 cells,docetaxel-sensitive PC-3 cells and docetaxel-resistant PC-3 cells.The constituents were analyzed by matrix-assisted laser desorption/ionizafion time of flight mass spectrometry(MALDI-TOF-MS) and the expression of HSP60 was detected.Results The expression of HSP60 was up-regulated in docetaxel-induced apoptotic PC-3 cells,and down-regulated in docetaxel-resistant PC-3 cells.Conclusion The expression level of HSP60 is high in the apoptotic PC-3 cells and low in the docetaxel-resistant PC-3 cells.It suggests that HSP60 might play an important role in apoptosis and docetaxel-resistance of PC-3 cells.
出处 《山东大学学报(医学版)》 CAS 北大核心 2012年第8期46-50,共5页 Journal of Shandong University:Health Sciences
基金 山东省自然科学基金(Z2007C07)
关键词 多西紫杉醇 热休克蛋白60 细胞凋亡 耐药性 蛋白质组学 Docetaxel Heat shock protein 60 Apoptosis Drug-resistance Proteomics
  • 相关文献

参考文献12

  • 1Macario A J L,Conway de Macario E. Molecular chaperones:Multiple functions,pathologies and potential applications[J].Frontiers in Bioscience,2007.2588-2600.
  • 2Macario A J L,Conway del Macario E. Chaperonopathies and chaperonotherapy[J].FEBS Letters,2007,(19):3681-3688.doi:10.1016/j.febslet.2007.04.030.
  • 3郑虹,耿明.HSP70、Caspase3在胶质细胞瘤中的表达及与肿瘤病理分级的关系[J].山东大学学报(医学版),2007,45(9):944-946. 被引量:6
  • 4Qi T,Han J,Cui Y. Comparative proteomic analysis for the detection of biomarkers in pancreatic ductal adenocarcinomas[J].Journal of Clinical Pathology,2008,(01):49-58.doi:10.1136/jcp.2006.044735.
  • 5Urushibara M,Kageyama Y,Akashi T. HSP60 may predict good pathological response to neoadjuvant chemoradiotherapy in bladder cancer[J].Japanese Journal of Clinical Oncology,2007,(01):56-61.doi:10.1093/jjco/hyl121.
  • 6Castilla C,Congregado B,Conde J M. Immunohistochemical expression of Hsp60 correlates with tumor progression and hormone resistance in prostate cancer[J].Urology,2010,(04):1017.el-1017.e6.
  • 7Kaighn M E,Narayan K S,Ohnuki Y. Establishment and characterization of a human prostatic carcinoma cell line(PC-3)[J].INVESTIGATIVE UROLOGY SERIES,1979,(01):16-23.
  • 8Beer T M,Pierce W C,Lowe B A. Phase Ⅱ study of weekly docetaxel in symptomatic androgen-independent prostate cancer[J].Annals of Oncology,2001,(09):1273-1279.doi:10.1023/A:1012258723075.
  • 9Petrylak D P,Tangen C M,Hussain M H. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer[J].New England Journal of Medicine,2004,(15):1513-1520.
  • 10Ghosh J C,Dohi T,Kang B H. Hsp60 regulation of tumor cell apoptosis[J].Journal of Biological Chemistry,2008,(08):5188-5194.

二级参考文献6

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部